- Features
- Performances
- Specifications
- References
Microporous gradient structure (dense and homogenous inside surface and porous outside area) provides "High permeability" and "Sharp cut-off" features.
![](/medical/en/apheresis/product/crrt/cureflo/img/img_01.jpg)
![](/medical/en/apheresis/product/crrt/cureflo/img/img_02.jpg)
![](/medical/en/apheresis/product/crrt/cureflo/img/img_03.jpg)
In-house data: Product: ACF-130W
Bovine plasma, TP=6.5g/dL, QB=100mL/min, Qf=10mL/min, Temp 37°C
![](/medical/en/apheresis/product/crrt/cureflo/img/img_03b.jpg)
Ronco et al. Blood Purif. 32:133-8, 2011
The change of WBC, C3a and granulocyte elastase is very small during treatment.
![](/medical/en/apheresis/product/crrt/cureflo/img/img_04.jpg)
Clinical data Patient: n=6
![](/medical/en/apheresis/product/crrt/cureflo/img/img_05b.jpg)
In-house data
Bovine blood, Ht=35%, TP=6.5g/dL, QB=100mL/min, Qf=10mL/min
24 hrs circulation
![](/medical/en/apheresis/product/crrt/cureflo/img/img_06b.jpg)
Clinical data
N=30, QB=100-250mL/min, Qf=1.2-3.2L/hr
Trademark
CUREFLO is a trademark of Asahi Kasei Medical Co., Ltd.
![](/medical/en/apheresis/product/crrt/cureflo/img/img_download.jpg)
CUREFLO
Please feel free to send us any questions you may have about our products and support.
Share your feelings and experiences when using our products.